SCHEMBL6985089

SCHEMBL6985089

N#Cc1ccc(C(=O)Nc2nc(C(=O)O)cs2)cc1

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.69
SMN1; SMN2 Q16637 5/20 0.69
ALDH1A1 P00352 4/20 0.69
KMT2A Q03164 3/20 0.54
ATM Q13315 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.52
MAPT P10636 6/20 0.51
LMNA P02545 2/20 0.50
RAB9A P51151 4/20 0.49
HTT P42858 3/20 0.49
MEN1 O00255 2/20 0.49
GAA P10253 2/20 0.49
HSP90AA1 P07900 1/20 0.49
MAPK1 P28482 1/20 0.49
NPC1 O15118 3/20 0.49
DUSP3 P51452 1/20 0.46
PKM P14618 1/20 0.46
SCD O00767 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6978613 0.86 SMN1; SMN2 (0.79) KDM4ESMN1; SMN2ALDH1A1KMT2AATM
SCHEMBL3603304 0.83 NPC1 (0.68) KDM4ESMN1; SMN2ALDH1A1KMT2AL3MBTL1
SCHEMBL3602994 0.82 MAPT (0.59) KDM4ESMN1; SMN2ALDH1A1KMT2AL3MBTL1
SCHEMBL3604622 0.82 KDM4E (0.59) KDM4ESMN1; SMN2ALDH1A1KMT2AL3MBTL1
SCHEMBL20530876 0.81 VCP (0.56) KDM4ESMN1; SMN2ALDH1A1KMT2AL3MBTL1
SCHEMBL6985901 0.78 SMN1; SMN2 (0.61) KDM4ESMN1; SMN2ALDH1A1KMT2AATM
SCHEMBL2754074 0.78 KDM4E (0.78) KDM4ESMN1; SMN2ALDH1A1KMT2AATM
SCHEMBL23742077 0.77 CA1 (0.55) KDM4ESMN1; SMN2ALDH1A1KMT2AL3MBTL1
SCHEMBL12249036 0.77 KDM4E (0.70) KDM4ESMN1; SMN2ALDH1A1KMT2AATM
SCHEMBL6984185 0.77 SMN1; SMN2 (0.59) KDM4ESMN1; SMN2ALDH1A1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0934938-B1 SUBSTITUTED BENZOYLAMINOTHIAZOLE DERIVATIVES AND DRUGS CONTAINING THE SAME ZERIA PHARM CO LTD (JP) 2003-01-15 EP disclosed
US-6121301-A ADMINISTERING TO PREVENT OR TREAT GASTROINTESTINAL DYSMOTILITY; COMPOUNDS SUCH AS 2-((N-(3-CYANOBENZOYL)AMINO)-4-((3-DIISOPROPYLAMINOPROPYL)AMINOCARBONYL)-1,3-THIAZOLE ZERIA PHARMACEUTICAL CO., LTD. (JP) 2000-09-19 US disclosed
EP-0934938-A1 SUBSTITUTED BENZOYLAMINOTHIAZOLE DERIVATIVES AND DRUGS CONTAINING THE SAME ZERIA PHARMACEUTICAL CO., LTD. (JP) 1999-08-11 EP disclosed